PE20020264A1 - Asociaciones dalfopristina/quinupristina con la cefpiroma - Google Patents

Asociaciones dalfopristina/quinupristina con la cefpiroma

Info

Publication number
PE20020264A1
PE20020264A1 PE2001000759A PE2001000759A PE20020264A1 PE 20020264 A1 PE20020264 A1 PE 20020264A1 PE 2001000759 A PE2001000759 A PE 2001000759A PE 2001000759 A PE2001000759 A PE 2001000759A PE 20020264 A1 PE20020264 A1 PE 20020264A1
Authority
PE
Peru
Prior art keywords
quinupristine
cepphiroma
dalfopristine
associations
cefphiroma
Prior art date
Application number
PE2001000759A
Other languages
English (en)
Inventor
Celine Feger
Philippe Moreillon
Jacques Vouillamoz
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of PE20020264A1 publication Critical patent/PE20020264A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Thyristors (AREA)
  • Peptides Or Proteins (AREA)

Abstract

SE REFIERE A UNA ASOCIACION SINERGICA QUE COMPRENDE UNA COMBINACION DE QUINUPRISTINA DALFOPRISTINA CON CEFPIROMA (SULFATO DEL ACIDO (Z)-7-[2-(2-AMINOTIAZO-4-LIL)-2-METOXIIMINOACETAMIDO]-3-(1-PIRIDINOMETIL)-3-CEFEM-4-CARBOXILICO); ADMINISTRANDOSE POR VIA INTRAVENOSA SIMULTANEA O SUCESIVAMENTE
PE2001000759A 2000-08-03 2001-07-26 Asociaciones dalfopristina/quinupristina con la cefpiroma PE20020264A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0010245A FR2812549B1 (fr) 2000-08-03 2000-08-03 Associations dalfopristine/quinupristine avec le cefpirome

Publications (1)

Publication Number Publication Date
PE20020264A1 true PE20020264A1 (es) 2002-05-20

Family

ID=8853264

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2001000759A PE20020264A1 (es) 2000-08-03 2001-07-26 Asociaciones dalfopristina/quinupristina con la cefpiroma

Country Status (29)

Country Link
US (2) US7005416B2 (es)
EP (1) EP1313500B1 (es)
JP (1) JP2004505926A (es)
KR (1) KR100808715B1 (es)
CN (1) CN1256982C (es)
AR (1) AR033992A1 (es)
AT (1) ATE279204T1 (es)
AU (2) AU8409501A (es)
BR (1) BR0112897A (es)
CA (1) CA2418023A1 (es)
CZ (1) CZ2003290A3 (es)
DE (1) DE60106463T2 (es)
DK (1) DK1313500T3 (es)
EA (1) EA007713B1 (es)
ES (1) ES2230358T3 (es)
FR (1) FR2812549B1 (es)
HK (1) HK1058305A1 (es)
HU (1) HU227455B1 (es)
IL (1) IL154237A0 (es)
MX (1) MXPA03000959A (es)
NO (1) NO20030483D0 (es)
NZ (1) NZ523982A (es)
PE (1) PE20020264A1 (es)
PL (1) PL204278B1 (es)
PT (1) PT1313500E (es)
SK (1) SK1202003A3 (es)
TN (1) TNSN01116A1 (es)
WO (1) WO2002011751A2 (es)
ZA (1) ZA200300903B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107420042B (zh) * 2017-09-25 2023-03-31 中国地质大学（武汉） 一种基于六自由度并联机构的海底钻机自动调平系统

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0867676A (ja) * 1994-03-30 1996-03-12 Eisai Kagaku Kk 保護アミノチアゾリル酢酸誘導体
US5464616A (en) * 1994-08-04 1995-11-07 Synphar Laboratories, Ind. 6β-substituted penicillanic acids as beta-lactamase inhibitors
US5686441A (en) * 1995-08-04 1997-11-11 Syphar Laboratories, Inc. Penam sulfones as β-lactamase inhibitors
FR2755857B1 (fr) * 1996-11-19 1998-12-24 Rhone Poulenc Rorer Sa Compositions pharmaceutiques stabilisees, a base de quinupristine et de dalfopristine et leur preparation
US6187746B1 (en) * 1997-12-16 2001-02-13 Rhone-Poulenc Rorer S.A. Pharmaceutical compositions based on dalfopristine and on quinupristine, and preparation thereof
US6465428B1 (en) * 1999-08-27 2002-10-15 Aventis Pharma S.A. Pharmaceutical combinations based on dalfopristine and quinupristine, and on cefepime

Also Published As

Publication number Publication date
JP2004505926A (ja) 2004-02-26
HU227455B1 (en) 2011-06-28
BR0112897A (pt) 2003-06-10
KR20030022351A (ko) 2003-03-15
ZA200300903B (en) 2003-11-10
NO20030483L (no) 2003-01-30
DE60106463D1 (de) 2004-11-18
EP1313500B1 (fr) 2004-10-13
MXPA03000959A (es) 2003-06-09
CN1256982C (zh) 2006-05-24
EA007713B1 (ru) 2006-12-29
ATE279204T1 (de) 2004-10-15
NZ523982A (en) 2004-10-29
DK1313500T3 (da) 2005-02-14
HUP0300682A3 (en) 2004-09-28
FR2812549B1 (fr) 2003-03-21
HUP0300682A2 (hu) 2003-08-28
IL154237A0 (en) 2003-07-31
NO20030483D0 (no) 2003-01-30
US7005416B2 (en) 2006-02-28
SK1202003A3 (en) 2003-07-01
AU2001284095B2 (en) 2007-04-05
KR100808715B1 (ko) 2008-02-29
AU8409501A (en) 2002-02-18
CN1449290A (zh) 2003-10-15
US20060122103A1 (en) 2006-06-08
TNSN01116A1 (fr) 2005-11-10
PT1313500E (pt) 2005-02-28
FR2812549A1 (fr) 2002-02-08
PL365075A1 (en) 2004-12-27
PL204278B1 (pl) 2009-12-31
WO2002011751A2 (fr) 2002-02-14
ES2230358T3 (es) 2005-05-01
CA2418023A1 (fr) 2002-02-14
EA200300214A1 (ru) 2003-06-26
EP1313500A2 (fr) 2003-05-28
US20020037890A1 (en) 2002-03-28
AR033992A1 (es) 2004-01-21
WO2002011751A3 (fr) 2002-06-13
CZ2003290A3 (cs) 2003-05-14
DE60106463T2 (de) 2005-10-13
HK1058305A1 (en) 2004-05-14

Similar Documents

Publication Publication Date Title
CO4810382A1 (es) Compuestos de indol agentes anti-inflamatorios/analgesicos
EE05302B1 (et) 4-fluoro-N-(indaan-2-l)bensamiidi kasutamine ja protsess ravimi valmistamiseks
DK1585739T3 (da) Substituerede arylcyclopropylacetamider som glucokinaseaktivatorer
UY28897A1 (es) Ácido 2-((2-(2-metilaminopirimidin-4-il)-1h-indol-5-carbonil)amino)-3-(fenilpiridin-2-ilamino)propiónico sustancialmente puro como inhibidor de la cinasa ikb
BR0002515A (pt) Derivados de 4-arilpiperidina para o tratamento do prurido
EE200200485A (et) Farmatseutilised kompositsioonid, mis sisaldavad asetidiini derivaate, uued asetidiini derivaadid ja nende valmistamismeetodid
CL2009001682A1 (es) Composición farmacéutica espontáneamente dispersable para administración oral que comprende n-benzoil-estaurosporina; método para incrementar los niveles de biodisponibilidad. (divisional de la solocitud 333-00).
AR031572A1 (es) Derivados de ribavirina, composiciones farmaceuticas y el uso de los mismos solo o en combinacion para la preparacion de medicamentos para erradicar hcv-arn en pacientes que tienen infeccion cronica de hepatitis c
UY29007A1 (es) Derivados de 2-carbamida-4-feniltiazol, su preparacinn, y su aplicacinn en terapcutica
ECSP066313A (es) Derivados de la piridazina y su uso como agentes terapéuticos
ECSP066315A (es) Derivados de la piridazina y su uso como agentes terapéuticos
PA8591701A1 (es) Derivados de pirrolopirimidina
BR0307960A (pt) N-aminoacetil-pirrolidina-2-carbonitrilas e seu uso como inibidores de ddp-iv
BR0001468A (pt) ácidos dioxiciclopentil hidroxânicos
TW200616940A (en) Novel hexafluoroisopropanol substituted ether derivatives
SE0100569D0 (sv) New compounds
HUP0101837A2 (hu) Mátrix metalloproteináz inhibítor N-hidroxi-2-(alkil-, aril-vagy heteroaril-szulfanil, szulfinil vagy szulfonil)-3-szubsztituált alkil, aril vagy heteroaril-amidok
SE0203825D0 (sv) Novel fused heterocycles and uses thereof
DOP2001000268A (es) Derivados puente de piperazina
ATE308540T1 (de) Antithrombosemittel
PE20020264A1 (es) Asociaciones dalfopristina/quinupristina con la cefpiroma
BR0015333A (pt) Derivados de isoxazol como inibidores de fosfodiesterase vii
AR032553A1 (es) Derivados de alfa-amino-n-hidroxi-acetamida.
SE0004101D0 (sv) New use
BR0308807A (pt) Compostos tiazol-2-il-imina como inibidores de pde-7

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed